Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Archetype Analysis Identifies Distinct Profiles in Renal Transplant Recipients with Transplant Glomerulopathy Associated with Allograft Survival.

Aubert O, Higgins S, Bouatou Y, Yoo D, Raynaud M, Viglietti D, Rabant M, Hidalgo L, Glotz D, Legendre C, Delahousse M, Shah N, Sis B, Campbell P, Mengel M, Jouven X, Van Huyen JD, Lefaucheur C, Loupy A.

J Am Soc Nephrol. 2019 Apr;30(4):625-639. doi: 10.1681/ASN.2018070777. Epub 2019 Mar 14.

PMID:
30872323
2.

The value of electron microscopy in the diagnosis of chronic renal allograft rejection.

Ivanyi B, Kemeny E, Szederkenyi E, Marofka F, Szenohradszky P.

Mod Pathol. 2001 Dec;14(12):1200-8.

3.

Morphologic patterns and treatment of transplant glomerulopathy: A retrospective analysis.

Abreu R, Carvalho F, Viana H, Mesquita I, Possante M, Aires I, Caeiro F, Silva C, Cotovio P, Ferreira A, Remédio F, Nolasco F.

Clin Transplant. 2017 Apr;31(4). doi: 10.1111/ctr.12915. Epub 2017 Feb 21.

PMID:
28135784
4.

Glomerular C3 Deposition Is an Independent Risk Factor for Allograft Failure in Kidney Transplant Recipients With Transplant Glomerulopathy.

Panzer SE, Joachim E, Parajuli S, Zhong W, Astor BC, Djamali A.

Kidney Int Rep. 2019 Feb 4;4(4):582-593. doi: 10.1016/j.ekir.2019.01.018. eCollection 2019 Apr.

5.

Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.

Loupy A, Vernerey D, Tinel C, Aubert O, Duong van Huyen JP, Rabant M, Verine J, Nochy D, Empana JP, Martinez F, Glotz D, Jouven X, Legendre C, Lefaucheur C.

J Am Soc Nephrol. 2015 Jul;26(7):1721-31. doi: 10.1681/ASN.2014040399. Epub 2015 Jan 2.

6.

Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy.

Sijpkens YW, Joosten SA, Wong MC, Dekker FW, Benediktsson H, Bajema IM, Bruijn JA, Paul LC.

Kidney Int. 2004 Jun;65(6):2409-18.

7.

Clinical and pathological analyses of transplant glomerulopathy cases.

Shimizu T, Ishida H, Toki D, Nozaki T, Omoto K, Tanabe K, Honda K, Koike J.

Nephrology (Carlton). 2014 Jun;19 Suppl 3:21-6. doi: 10.1111/nep.12243.

PMID:
24842817
8.

Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.

Gosset C, Viglietti D, Rabant M, Vérine J, Aubert O, Glotz D, Legendre C, Taupin JL, Duong Van-Huyen JP, Loupy A, Lefaucheur C.

Kidney Int. 2017 Sep;92(3):729-742. doi: 10.1016/j.kint.2017.03.033. Epub 2017 May 26.

PMID:
28554738
9.

T-bet-positive mononuclear cell infiltration is associated with transplant glomerulopathy and interstitial fibrosis and tubular atrophy in renal allograft recipients.

Yadav B, Prasad N, Agrawal V, Jain M, Agarwal V, Jaiswal A, Bhadauria D, Sharma RK, Gupta A.

Exp Clin Transplant. 2015 Apr;13(2):145-51.

10.

Development and validation of a prognostic index for allograft outcome in kidney recipients with transplant glomerulopathy.

Patri P, Seshan SV, Matignon M, Desvaux D, Lee JR, Lee J, Dadhania DM, Serur D, Grimbert P, Hartono C, Muthukumar T.

Kidney Int. 2016 Feb;89(2):450-8.

11.

Histologic phenotype on 1-year posttransplantation biopsy and allograft survival in HLA-incompatible kidney transplants.

Sharif A, Kraus ES, Zachary AA, Lonze BE, Nazarian SM, Segev DL, Alachkar N, Arend LJ, Bagnasco SM, Racusen LC, Montgomery RA.

Transplantation. 2014 Mar 15;97(5):541-7. doi: 10.1097/01.TP.0000442513.27641.7e.

PMID:
24521779
12.

An evaluation of the Banff classification of early renal allograft biopsies and correlation with outcome.

Bates WD, Davies DR, Welsh K, Gray DW, Fuggle SV, Morris PJ.

Nephrol Dial Transplant. 1999 Oct;14(10):2364-9.

PMID:
10528659
13.

Transplant glomerulopathy.

Filippone EJ, McCue PA, Farber JL.

Mod Pathol. 2018 Feb;31(2):235-252. doi: 10.1038/modpathol.2017.123. Epub 2017 Oct 13. Review.

14.

Clinical, Histological, and Molecular Markers Associated With Allograft Loss in Transplant Glomerulopathy Patients.

Kamal L, Broin PÓ, Bao Y, Ajaimy M, Lubetzky M, Gupta A, de Boccardo G, Pullman J, Golden A, Akalin E.

Transplantation. 2015 Sep;99(9):1912-8. doi: 10.1097/TP.0000000000000598.

PMID:
25675205
15.

Proteinuria, Estimated Glomerular Filtration Rate and Urinary Retinol-Binding Protein as Clinical Predictors of Long-Term Allograft Outcomes in Transplant Glomerulopathy.

Li X, Chen J, Cheng D, Wang R, Wang W, Zhang M, Xu F, Wen J, Tang Z.

Kidney Blood Press Res. 2018;43(6):1842-1851. doi: 10.1159/000495816. Epub 2018 Dec 7.

16.

[Progression of chronic renal insufficiency in chronic rejection: the role of chronic transplantation glomerulopathy].

Savić M, Djukanović Lj, Sinkjić M, Blagojević R, Ostrić V.

Srp Arh Celok Lek. 1996 Jan-Feb;124(1-2):11-3. Serbian.

PMID:
9102807
17.

Histopathologic Features that Predict Transplant Glomerulopathy Progression in a Chinese Cohort.

Li X, Chen J, Cheng D, Wang W, Xie K, Zhang M, Xu F, Wen J, Tang Z.

Am J Nephrol. 2019 Apr 16;49(6):425-434. doi: 10.1159/000500043. [Epub ahead of print]

PMID:
30991390
18.

An analysis of transplant glomerulopathy and thrombotic microangiopathy in kidney transplant biopsies.

Sreedharanunni S, Joshi K, Duggal R, Nada R, Minz M, Sakhuja V.

Transpl Int. 2014 Aug;27(8):784-92. doi: 10.1111/tri.12331. Epub 2014 May 24.

19.

De novo and recurrent membranous glomerulopathy following kidney transplantation.

Berger BE, Vincenti F, Biava C, Amend WJ Jr, Feduska N, Salvatierra O Jr.

Transplantation. 1983 Apr;35(4):315-9.

PMID:
6340284
20.

Antibody-Mediated Rejection Due to Preexisting versus De Novo Donor-Specific Antibodies in Kidney Allograft Recipients.

Aubert O, Loupy A, Hidalgo L, Duong van Huyen JP, Higgins S, Viglietti D, Jouven X, Glotz D, Legendre C, Lefaucheur C, Halloran PF.

J Am Soc Nephrol. 2017 Jun;28(6):1912-1923. doi: 10.1681/ASN.2016070797. Epub 2017 Mar 2.

Supplemental Content

Support Center